DE69224069T2 - Pharmazeutisches kombinationspräparat, das ein uricosurisches mittel und einen excitatorischen aminosäure-antagonisten enthält - Google Patents
Pharmazeutisches kombinationspräparat, das ein uricosurisches mittel und einen excitatorischen aminosäure-antagonisten enthältInfo
- Publication number
- DE69224069T2 DE69224069T2 DE69224069T DE69224069T DE69224069T2 DE 69224069 T2 DE69224069 T2 DE 69224069T2 DE 69224069 T DE69224069 T DE 69224069T DE 69224069 T DE69224069 T DE 69224069T DE 69224069 T2 DE69224069 T2 DE 69224069T2
- Authority
- DE
- Germany
- Prior art keywords
- amino acid
- acid antagonist
- excitatoric
- product containing
- pharmaceutical combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75640191A | 1991-09-09 | 1991-09-09 | |
PCT/US1992/007540 WO1993004688A1 (en) | 1991-09-09 | 1992-09-02 | Pharmaceutical preparation containing an uricosuric and an excitatory amino acid antagonist |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69224069D1 DE69224069D1 (de) | 1998-02-19 |
DE69224069T2 true DE69224069T2 (de) | 1998-07-02 |
Family
ID=25043303
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69224069T Expired - Fee Related DE69224069T2 (de) | 1991-09-09 | 1992-09-02 | Pharmazeutisches kombinationspräparat, das ein uricosurisches mittel und einen excitatorischen aminosäure-antagonisten enthält |
Country Status (16)
Country | Link |
---|---|
US (4) | US5407935A (de) |
EP (1) | EP0603301B1 (de) |
JP (1) | JP3218038B2 (de) |
AT (1) | ATE162075T1 (de) |
AU (1) | AU660717B2 (de) |
CA (1) | CA2115442C (de) |
DE (1) | DE69224069T2 (de) |
DK (1) | DK0603301T3 (de) |
ES (1) | ES2113957T3 (de) |
GR (1) | GR3026369T3 (de) |
MX (1) | MX9205127A (de) |
NO (1) | NO307645B1 (de) |
NZ (1) | NZ244243A (de) |
PT (1) | PT100850B (de) |
WO (1) | WO1993004688A1 (de) |
ZA (1) | ZA926837B (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE162075T1 (de) * | 1991-09-09 | 1998-01-15 | Warner Lambert Co | Pharmazeutisches kombinationspräparat, das ein uricosurisches mittel und einen excitatorischen aminosäure-antagonisten enthält |
US5318985A (en) * | 1991-12-20 | 1994-06-07 | Merrell Dow Pharmaceuticals Inc. | Potentiation of NMDA antagonists |
JPH07505908A (ja) * | 1992-09-28 | 1995-06-29 | マックセチーニ、マリア ルイザ | Nmda受容体のアロステリックモジュレーター |
US5854217A (en) | 1992-09-28 | 1998-12-29 | Bearsden Bio, Inc. | Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function |
CA2261568A1 (en) | 1996-07-22 | 1998-01-29 | University Of Utah Research Foundation | Conantokins |
AU735389B2 (en) | 1996-07-22 | 2001-07-05 | Cognetix, Inc. | Use of conantokins |
US6277825B1 (en) | 1996-07-22 | 2001-08-21 | University Of Utah Research Foundation | Use of conantokins for treating pain |
IL125950A0 (en) * | 1997-09-05 | 1999-04-11 | Pfizer Prod Inc | Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy |
WO1999061008A2 (en) * | 1998-05-26 | 1999-12-02 | Peter Louis Carlen | Compositions and methods for alleviating impaired mental function, memory loss and reducing recovery time in anaesthetized mammals |
US6399574B1 (en) | 2000-03-22 | 2002-06-04 | University Of Utah Research Foundation | Use of conantokins |
EP1317258B1 (de) | 2000-06-28 | 2009-02-11 | Merck & Co., Inc. | Verwendung von allopurinol zur behandlung von bluthochdruck |
US20080051428A1 (en) * | 2002-05-15 | 2008-02-28 | Davis Paul J | Pyrroloquinoline quinone drugs and methods of use thereof |
US7276514B2 (en) * | 2002-05-15 | 2007-10-02 | Charitable Leadership Foundation - Medical Technology Acceleration Program | Pyrroloquinoline quinone drugs for treatment of cardiac injury and methods of use thereof |
US20040152694A1 (en) * | 2003-02-04 | 2004-08-05 | Istvan Kurucz | Methods and compositions for treating inflammatory disorders of the airways |
US20050209317A1 (en) * | 2004-03-22 | 2005-09-22 | Apkarian A V | Method and compositions for treatment of chronic neuropathic pain |
US8461223B2 (en) * | 2005-04-07 | 2013-06-11 | Aspen Aerogels, Inc. | Microporous polycyclopentadiene-based aerogels |
ITFI20050083A1 (it) * | 2005-04-29 | 2006-10-30 | Univ Firenze | Uso dell'acido chinurenico per la prevenzione e il trattamento dello shock |
WO2006121995A2 (en) | 2005-05-09 | 2006-11-16 | Tap Pharmaceutical Products, Inc. | Methods for treating nephrolithiasis |
US9181486B2 (en) | 2006-05-25 | 2015-11-10 | Aspen Aerogels, Inc. | Aerogel compositions with enhanced performance |
EP2338492A1 (de) | 2009-12-24 | 2011-06-29 | Universidad del Pais Vasco | Verfahren und Zusammensetzung zur Behandlung von Alzheimer |
KR101797936B1 (ko) | 2010-09-10 | 2017-11-15 | 다케다 파마슈티칼스 유에스에이, 인코포레이티드 | 테오필린과 페북소스타트의 병용 치료 방법 |
US10806711B2 (en) | 2011-08-12 | 2020-10-20 | University Of Cincinnati | Method of treating acute decompensated heart failure with probenecid |
WO2014160153A1 (en) | 2013-03-13 | 2014-10-02 | University Of Cincinnati | Treatment of a diastolic cardiac dysfunction with a trpv2 receptor agonist |
US20170143681A1 (en) | 2015-11-02 | 2017-05-25 | Apkarian Technologies Llc | Methods and compositions for treating pain |
EP3427729A1 (de) * | 2017-07-13 | 2019-01-16 | Paris Sciences et Lettres - Quartier Latin | Probenecid zur behandlung von epileptischen erkrankungen, störungen oder zuständen |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4812458A (en) * | 1986-09-16 | 1989-03-14 | A/S Ferrosan | 6,7-disubstituted-2,3-dihydroxyquinoxaline compounds, pharmaceutical compositions thereof, and their use as neuroleptics |
DK146787A (da) * | 1987-03-23 | 1988-09-24 | Ferrosan | Heterocykliske forbindelser, deres fremstilling og anvendelse |
ATE168989T1 (de) * | 1991-02-28 | 1998-08-15 | Merrell Pharma Inc | Nmda antagonisten |
ATE162075T1 (de) * | 1991-09-09 | 1998-01-15 | Warner Lambert Co | Pharmazeutisches kombinationspräparat, das ein uricosurisches mittel und einen excitatorischen aminosäure-antagonisten enthält |
-
1992
- 1992-09-02 AT AT92919882T patent/ATE162075T1/de not_active IP Right Cessation
- 1992-09-02 WO PCT/US1992/007540 patent/WO1993004688A1/en active IP Right Grant
- 1992-09-02 AU AU25943/92A patent/AU660717B2/en not_active Ceased
- 1992-09-02 CA CA002115442A patent/CA2115442C/en not_active Expired - Fee Related
- 1992-09-02 EP EP92919882A patent/EP0603301B1/de not_active Expired - Lifetime
- 1992-09-02 DE DE69224069T patent/DE69224069T2/de not_active Expired - Fee Related
- 1992-09-02 ES ES92919882T patent/ES2113957T3/es not_active Expired - Lifetime
- 1992-09-02 DK DK92919882T patent/DK0603301T3/da active
- 1992-09-02 JP JP50544593A patent/JP3218038B2/ja not_active Expired - Fee Related
- 1992-09-07 NZ NZ244243A patent/NZ244243A/en unknown
- 1992-09-08 ZA ZA926837A patent/ZA926837B/xx unknown
- 1992-09-08 MX MX9205127A patent/MX9205127A/es not_active IP Right Cessation
- 1992-09-08 PT PT100850A patent/PT100850B/pt not_active IP Right Cessation
-
1993
- 1993-04-19 US US08/049,228 patent/US5407935A/en not_active Expired - Fee Related
-
1994
- 1994-03-08 NO NO940809A patent/NO307645B1/no not_active IP Right Cessation
-
1995
- 1995-10-05 US US08/539,398 patent/US5627168A/en not_active Expired - Fee Related
-
1996
- 1996-12-31 US US08/775,637 patent/US5767119A/en not_active Expired - Fee Related
-
1998
- 1998-03-13 GR GR980400554T patent/GR3026369T3/el unknown
- 1998-03-27 US US09/049,495 patent/US5942513A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH06510544A (ja) | 1994-11-24 |
CA2115442A1 (en) | 1993-03-18 |
NO940809L (no) | 1994-03-08 |
NZ244243A (en) | 1995-07-26 |
EP0603301B1 (de) | 1998-01-14 |
DE69224069D1 (de) | 1998-02-19 |
PT100850B (pt) | 1999-07-30 |
ZA926837B (en) | 1994-03-08 |
US5627168A (en) | 1997-05-06 |
NO307645B1 (no) | 2000-05-08 |
JP3218038B2 (ja) | 2001-10-15 |
ES2113957T3 (es) | 1998-05-16 |
AU660717B2 (en) | 1995-07-06 |
DK0603301T3 (da) | 1998-09-14 |
NO940809D0 (no) | 1994-03-08 |
US5942513A (en) | 1999-08-24 |
WO1993004688A1 (en) | 1993-03-18 |
EP0603301A1 (de) | 1994-06-29 |
MX9205127A (es) | 1993-07-01 |
GR3026369T3 (en) | 1998-06-30 |
CA2115442C (en) | 2003-09-23 |
AU2594392A (en) | 1993-04-05 |
ATE162075T1 (de) | 1998-01-15 |
US5407935A (en) | 1995-04-18 |
US5767119A (en) | 1998-06-16 |
PT100850A (pt) | 1993-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69224069T2 (de) | Pharmazeutisches kombinationspräparat, das ein uricosurisches mittel und einen excitatorischen aminosäure-antagonisten enthält | |
ES2169127T3 (es) | Nuevos carbamatos y ureas como modificadores de la resistencia multi-farmaco. | |
IS4073A (is) | Nýtt fjölvirknislyf gegn aukningu mótstöðu | |
DE68929460T2 (de) | Substituierte Phenylpyrimidine Derivate, für die Behandlung oder Prevention von ZNS-Erkrankungen | |
EE03969B1 (et) | (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid | |
NO1994018I1 (no) | Mometasonfuroat | |
ATE251140T1 (de) | N-(2 oxoacetyl oder sulphonyl)- pyrrolidine/piperidine-2-carbonsäurederivate mit verbesserter multi-drug resistenz aktivität | |
DE69611106T2 (de) | Kosmetische, dermatologische oder pharmazeutische Zusammensetzung, enthaltend einen Antagonisten der CGRP | |
PT705100E (pt) | Guanidinas substituidas terapeuticas | |
BG101118A (en) | Therapeutical compounds | |
FI972308A0 (fi) | 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi | |
RU95111308A (ru) | Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция | |
TR200100637T2 (tr) | Yeni doğal ürün türevleri | |
BR9814945A (pt) | Utilização de fanquinona para o tratamento de doença de alzheimer, composição farmacêutica e kit | |
ATE112276T1 (de) | Aryl-chinolyl-substituierte 1,4-dihydropyridin- dicarbonsäurederivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln. | |
ATE245421T1 (de) | Pharmazeutische zusammensetzung welche riluzol und gabapentin enthält zur behandung von motoneuronalen krankheiten | |
ATE96039T1 (de) | Arzneimittel und ihre verwendung zur behandlung von parasitosen. | |
FI972676A (fi) | 4,4-(disubstituoitu)sykloheksan-olimonomeerejä ja vastaavia yhdisteitä | |
ATE180167T1 (de) | Inhibition der ausscheidung von natrium durch die na-k-atpase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |